2m 2m 2m 2m 2m 2m 2m
XBiotech (XBIT)
NASDAQ
$2.25+$0.02 (+0.67%)
Price as of Aug 03, 2026 3:13 PM EDT- $68.0MMarket Cap
- -21.75%1-Year Change
- BiotechnologyIndustry
XBiotech (XBIT)
$2.25+$0.02 (+0.67%)
XBIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.23 | ||
Change | -$0.01 (-0.45%) | ||
Open | $2.25 | ||
High | $2.26 | ||
Low | $2.22 | ||
Previous Close | $2.24 | ||
Volume | 37,802 | ||
30-Day Average Volume | 41,655 | ||
1-Week Change | -1.76% | ||
1-Month Change | -3.04% | ||
1-Year Change | -21.75% | ||
3-Year Change | -55.67% | ||
5-Year Change | -86.23% | ||
Fundamentals | |||
Shares Outstanding | 30.5M | ||
Total Assets | $139.8M | ||
Market Cap | $68.0M | ||
Enterprise Value | -$47.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$9.0M | ||
EBIT | -$5.5M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $114.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | 9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -12 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/15/2021 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield